JAK2 and hepatocellular carcinoma: Furthermore, bioinformatics analysis of publicly available dataset (GSE14323) by using Oncomine an online tool (https://www.oncomine.org/resource/) [23] also demonstrated (Figures 1(e) and 1(f)) the expression of JAK2 and α7nAChR, considerably higher in the HCC patients samples compared to the normal counterpart, whereas the expression of α7nAChR correlates positively with the expression of JAK2 expression in HCC patients' samples (Figure 1(g)), and the poor overall survival of HCC patients was observed in patients exhibiting higher expression of α7nAChR (Figure 1(h)).